Ann Arbor, Michigan (PRWEB) December 15, 2022 Genomenon, Inc., an AI-driven genomics company, today announced the publication of a paper in the Orphanet
- Article in Orphanet Journal of Rare Diseases estimates genetic prevalence of ENPP1 Deficiency at 1 in 64,000 pregnancies, more than tripling prior estimate - - Company estimates addressable patient. | December 5, 2022